ALBANO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 13.845
EU - Europa 7.059
AS - Asia 5.520
SA - Sud America 1.430
Continente sconosciuto - Info sul continente non disponibili 752
AF - Africa 311
OC - Oceania 4
Totale 28.921
Nazione #
US - Stati Uniti d'America 13.588
SG - Singapore 2.260
DE - Germania 2.153
IT - Italia 1.644
CN - Cina 1.151
BR - Brasile 1.089
RU - Federazione Russa 915
HK - Hong Kong 702
SE - Svezia 634
GB - Regno Unito 546
VN - Vietnam 365
FR - Francia 331
FI - Finlandia 309
BD - Bangladesh 211
IN - India 198
UA - Ucraina 144
CA - Canada 118
CI - Costa d'Avorio 113
AR - Argentina 111
ID - Indonesia 109
IQ - Iraq 77
ZA - Sudafrica 71
MX - Messico 65
PK - Pakistan 63
CO - Colombia 59
JP - Giappone 57
PL - Polonia 56
TR - Turchia 50
VE - Venezuela 46
EC - Ecuador 45
BE - Belgio 43
NL - Olanda 40
ES - Italia 38
IE - Irlanda 35
PH - Filippine 33
AT - Austria 32
SA - Arabia Saudita 32
CL - Cile 29
TN - Tunisia 28
MA - Marocco 27
CZ - Repubblica Ceca 25
MY - Malesia 24
UZ - Uzbekistan 24
PE - Perù 20
JO - Giordania 18
LT - Lituania 18
NP - Nepal 18
JM - Giamaica 16
CR - Costa Rica 15
KE - Kenya 15
EG - Egitto 14
PY - Paraguay 14
RO - Romania 14
KZ - Kazakistan 13
ET - Etiopia 12
RS - Serbia 12
CH - Svizzera 11
TH - Thailandia 11
AZ - Azerbaigian 10
BO - Bolivia 10
KR - Corea 10
PT - Portogallo 10
IR - Iran 9
KG - Kirghizistan 9
AE - Emirati Arabi Uniti 8
HN - Honduras 8
AL - Albania 7
IL - Israele 7
LB - Libano 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
GR - Grecia 6
GT - Guatemala 6
BH - Bahrain 5
DZ - Algeria 5
HU - Ungheria 5
NI - Nicaragua 5
PA - Panama 5
SV - El Salvador 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GE - Georgia 4
HR - Croazia 4
MD - Moldavia 4
MU - Mauritius 4
OM - Oman 4
SN - Senegal 4
AM - Armenia 3
AU - Australia 3
BY - Bielorussia 3
CY - Cipro 3
MT - Malta 3
QA - Qatar 3
UY - Uruguay 3
BG - Bulgaria 2
CG - Congo 2
EE - Estonia 2
GA - Gabon 2
Totale 28.132
Città #
Fairfield 1.541
Ashburn 1.469
Singapore 1.192
Woodbridge 898
San Jose 863
Chandler 836
Houston 726
Hong Kong 696
Seattle 673
Milan 543
Cambridge 530
Nyköping 517
Wilmington 462
New York 396
Beijing 391
Ann Arbor 351
Council Bluffs 318
Jacksonville 312
Los Angeles 264
Lauterbourg 204
Rome 185
Lawrence 181
Roxbury 176
Helsinki 165
Bari 146
Dallas 143
Munich 134
Nanjing 117
Abidjan 112
Ho Chi Minh City 109
Des Moines 106
Santa Clara 106
Brooklyn 104
Boardman 94
Falkenstein 88
São Paulo 85
Princeton 83
Jakarta 79
Columbus 69
Hanoi 65
Buffalo 63
Inglewood 63
San Diego 63
London 61
Moscow 55
Chicago 54
Frankfurt am Main 52
Dong Ket 50
Tokyo 49
Figino 48
Paris 47
Warsaw 44
Brussels 42
Montreal 38
Redwood City 38
Atlanta 37
Denver 37
Nanchang 37
Rio de Janeiro 37
Turku 37
Nuremberg 36
Johannesburg 35
Dublin 33
Naples 32
Phoenix 32
Belo Horizonte 30
Shenyang 30
Baghdad 29
Chennai 29
Changsha 27
Jiaxing 27
Marseille 27
Turin 27
Boston 26
Dearborn 26
Dhaka 26
Tianjin 26
Pune 25
The Dalles 25
Hebei 24
Mexico City 24
Orem 24
Brasília 23
Guangzhou 23
San Francisco 23
Shanghai 23
Bologna 22
Tashkent 22
Toronto 22
Lahore 19
Mumbai 19
Poplar 18
Curitiba 17
Guayaquil 17
Quito 17
Bogotá 16
Falls Church 16
Portsmouth 16
Salvador 16
Stockholm 16
Totale 17.446
Nome #
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 259
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 255
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 238
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 227
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 225
Monosomal karyotype in myeloid neoplasias: a literature review 225
A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma 216
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 215
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 215
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 214
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 211
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 206
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 204
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy 204
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 203
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 201
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 199
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 199
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 197
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 196
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 190
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 189
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 189
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 187
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 186
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 185
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 183
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 183
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 179
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 178
Non-treatment-related chronic myeloid leukemia as a second malignancy 177
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 175
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 173
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 172
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 172
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 172
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 172
Decreased TET2 gene expression during chronic myeloid leukemia progression 171
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 171
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 168
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 168
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 167
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 165
Concomitant occurrence of BCR-ABL and JAK2V617F mutation 164
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 163
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 163
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 163
Similar mechanisms formed ring markers containing chromosome 12 pericentromeric region in two patients with therapy-related acute myeloid leukemia 162
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 162
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients 162
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 161
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 160
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 160
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 159
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 157
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 157
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 157
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 157
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 156
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 155
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 154
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 154
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 153
Bone marrow ectopic expression of a non-coding RNA in childhood T-cell acute lymphoblastic leukemia with a novel t(2;11)(q11.2;p15.1) translocation 153
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 153
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 152
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 151
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 151
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 148
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia 148
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 147
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 147
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 147
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience 147
A rare case of IgM-Multiple Myeloma 145
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 145
FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients 145
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 144
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 143
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 142
Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia 141
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 141
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link? 140
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile. 140
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 140
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 139
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 139
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP 138
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 138
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia 138
Concomitant tetrasomy 3q and trisomy 18 in CD5- CD13+ chronic lymphocytic leukemia 137
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients 137
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 137
Characterization of der(9) deletions in CML patients 136
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 136
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto 136
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale 134
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial 134
Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia 133
RUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia 133
Totale 16.815
Categoria #
all - tutte 118.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.179


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.146 0 0 19 34 65 132 70 58 122 124 223 299
2022/20232.244 308 307 157 153 228 315 38 270 347 11 49 61
2023/20241.069 79 138 56 58 106 405 24 43 5 29 17 109
2024/20254.062 152 68 256 178 156 338 506 348 183 249 556 1.072
2025/20269.505 1.174 400 612 1.025 1.111 540 1.006 278 1.052 922 304 1.081
2026/2027978 293 458 227 0 0 0 0 0 0 0 0 0
Totale 28.921